BRIEF published on 02/20/2025 at 07:35, 1 year 2 months ago ABIONYX Pharma reçoit un soutien de 8,7 millions d'euros pour son projet sur le sepsis France 2030 ABIONYX Pharma Sepsis Soutien Financier Biomédicament
BRIEF published on 02/20/2025 at 07:35, 1 year 2 months ago ABIONYX Pharma receives €8.7 million in support for its sepsis project Financial Support France 2030 ABIONYX Pharma Sepsis Biomedicine
PRESS RELEASE published on 02/20/2025 at 07:30, 1 year 2 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma reçoit 8,7 M€ de soutien de l’Etat pour combattre le sepsis, 3ème cause de décès mondiale, grâce à son biomédicament CER-001 France 2030 ABIONYX Pharma Sepsis Soutien Financier Biomédicament
BRIEF published on 12/11/2024 at 12:16, 1 year 4 months ago Franchissement de seuil par la CDC dans ABIONYX PHARMA Droits De Vote Franchissement De Seuil CDC ABIONYX Pharma Bpifrance Participations
BRIEF published on 12/11/2024 at 12:16, 1 year 4 months ago Threshold crossing by the CDC in ABIONYX PHARMA Voting Rights CDC Threshold Crossing ABIONYX Pharma Bpifrance Participations
BRIEF published on 12/11/2024 at 12:13, 1 year 4 months ago Franchissement de seuil par Bpifrance dans ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions Bpifrance ABIONYX
BRIEF published on 12/11/2024 at 12:13, 1 year 4 months ago Threshold crossing by Bpifrance in ABIONYX PHARMA Voting Rights Actions Threshold Crossing Bpifrance ABIONYX
PRESS RELEASE published on 12/11/2024 at 12:11, 1 year 4 months ago Franchissement de seuil Déclaration de franchissement de seuil de 5% des droits de vote de ABIONYX PHARMA par la Caisse des dépôts et consignations via Bpifrance Participations Franchissement De Seuil Caisse Des Dépôts Et Consignations ABIONYX Pharma Bpifrance Participations 5% Droits De Vote
PRESS RELEASE published on 12/11/2024 at 12:08, 1 year 4 months ago Franchissement de seuil Bpifrance declared indirectly holding 4.67% of Abionyx Pharma's capital and 7.34% of voting rights as of December 5, 2024 Déclaration Franchissement De Seuil AMF Bpifrance ABIONYX Pharma
BRIEF published on 12/10/2024 at 10:51, 1 year 4 months ago Franchissement de seuil par Cyrille Tupin chez ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions ABIONYX Pharma Cyrille Tupin
Published on 05/09/2026 at 00:00, 1 day 1 hour ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 6 hours 24 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 4 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 6 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 6 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 6 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 6 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 6 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 6 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 6 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
